Download in electronic PDF format for $75

Abstract:  In the United States, the most common cancers of the head and neck are those of the oral cavity and pharynx. In 2007, oral cancer will be diagnosed in more than 37,000 Americans and will claim more than 7,500 lives. The report presented here describes a case of extraordinary pain in a woman with metastatic adenocarcinoma of the hard palate. At the time of her referral for hospice care, she was experiencing excruciating, unremitting, chronic pain graded 10 of 10 on a standard pain scale. Her analgesic treatment consisted of opioids prescribed in increasingly higher doses until they were ineffective, the effects of treatment could not be tolerated, or she could not swallow the quantity of oral medication needed to provide relief. Only the opioid levorphanol has provided effective analgesia with few adverse effects, and the patient’s malignant pain is manageable with far fewer doses of oral medication. Comments from the patient’s physician, the pain management specialist who provided the successful conversion be

Related Keywords: Jack P. McNulty, MD, FACP, FAAHPM, levorphanol, N-methyl-D-aspartate receptor antagonist, NMDA blocker, oral cancer, pain control, pain management, case report, analgesia, analgesics, adverse effects, side effects, supportive care, opioid conversion

Related Categories: CANCER AND AIDS, EAR NOSE THROAT, FORMULATIONS, PAIN MANAGEMENT, CASE REPORTS, NEUROLOGY

Printer-Friendly Version